EGFR targeting of [177Lu] gold nanoparticles to colorectal and breast tumour cells: Affinity, duration of binding and growth inhibition of Cetuximab-resistant cells

Shabbir, Rekaya; Mingarelli, Marco; Cabello, Gema; Herk, Marcel van; Choudhury, Ananya; Smith, T.

doi:10.1016/j.jksus.2021.101573

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

EGFR targeting of [177Lu] gold nanoparticles to colorectal and breast tumour cells: Affinity, duration of binding and growth inhibition of Cetuximab-resistant cells

Cited by 4 publications

References 34 publications

Development of Biocompatible Nanocarriers for the Treatment of Colorectal Cancer

Development of Biocompatible Nanocarriers for the Treatment of Colorectal Cancer

Monoclonal Antibodies in Nanosystems as a Strategy for Cancer Treatment

Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies

Contact Info

Product

Resources

About